MySebDermTeam provides trusted connection,
information, and support to accelerate diagnosis and
treatment
SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- MyHealthTeam,
creator of the largest and fastest-growing social networks for
people living with chronic health conditions, today launched
MySebDermTeam, an online community for those living with seborrheic
dermatitis to find the people, support, and medically-reviewed
information they need to better manage their condition. Created by
MyHealthTeam, with sponsorship by Arcutis Biotherapeutics, an early
commercial-stage company focused on developing meaningful
innovations in immuno-dermatology, MySebDermTeam empowers
individuals with information that helps them more effectively work
with doctors throughout their seborrheic dermatitis diagnosis and
treatment journey.
"Despite impacting up to 5% of the population, seborrheic
dermatitis is widely under-diagnosed and under-treated,
particularly among underserved populations," said Frank Watanabe, President and CEO of Arcutis.
"We are committed to meeting those living with seborrheic
dermatitis where they are and providing understandable education
and community support to help them better diagnose and manage their
condition."
A recent nationwide survey of 300 people diagnosed with
seborrheic dermatitis revealed the significant need for education
about this condition. On average, it took respondents 3.6 years to
seek care from symptom onset, and 1 year if symptoms were severe.
Additionally, the survey found that 71% of respondents had not
heard of seborrheic dermatitis prior to their diagnosis, and 56%
found it hard to find information online about the disease.
MyHealthTeam will work with seborrheic dermatitis experts to
develop free educational content for MySebDermTeam, which will
include:
- A guide to tracking symptoms, which can help accelerate
the path to diagnosis;
- Representative images showing what seborrheic dermatitis
looks like on different body parts and skin tones;
- Interviews with medical experts who specialize in
treating the disease;
- Insights into the latest research on and treatment options
for seborrheic dermatitis; and
- Information about the quality of life and mental
health impacts of seborrheic dermatitis.
"With any visible skin condition that takes years to diagnose
and causes physical and emotional pain, it is urgent to go directly
to patients with the support and information they need," said
Eric Peacock, Cofounder and CEO of
MyHealthTeam. "Members of MySebDermTeam will learn from each other
and from our panel of dermatological experts, giving them a safe
alternative to 'Dr. Google.' We are thrilled that Arcutis will be
sponsoring this resource for the community."
Up to 5% of adults suffer from seborrheic dermatitis, and
the condition often comes with significant physical discomfort as
well as social stigma. Seborrheic dermatitis is a chronic or
recurrent inflammatory skin disease that causes red patches covered
with large, greasy, flaking yellow-gray scales, and persistent
itch. It often occurs on the scalp or along the hairline, along and
between the eyebrows, on the cheeks and near the nostrils, and it
can spread to other parts of the body including the back, chest,
armpits, and genitals.
MySebDermTeam is the 45th condition-specific social network from
MyHealthTeam and builds on the company's strength in dermatology,
with a portfolio that includes MyEczemaTeam, myHSteam,
MyHyperhidrosisTeam, MyPrurigoTeam, MyPsoriasisTeam, and
MyVitiligoTeam.
About Arcutis
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical
dermatology company that champions meaningful innovation to address
the urgent needs of patients living with immune-mediated
dermatological diseases and conditions. With a commitment to
solving the most persistent patient challenges in dermatology,
Arcutis harnesses our unique dermatology development platform
coupled with our dermatology expertise to build differentiated
therapies against biologically validated targets. Arcutis'
dermatology development platform includes a robust pipeline with
multiple clinical programs for a range of inflammatory
dermatological conditions including scalp and body psoriasis,
atopic dermatitis, and seborrheic dermatitis. For more information,
visit www.arcutis.com or follow Arcutis on LinkedIn, Facebook, and
Twitter.
About MyHealthTeam
MyHealthTeam believes that if you are diagnosed with a
chronic condition, it should be easy to find and connect with
others like you. MyHealthTeam creates social networks that provide
support and information for people living with a chronic health
condition. Millions of people have joined one of the company's 45
highly engaged communities focusing on the following conditions:
Alzheimer's, amyloidosis, asthma, autism, autoimmune hemolytic
anemia, breast cancer, COPD, chronic pain, COVID-19, Crohn's and
ulcerative colitis, depression, diabetes (type 2), eczema,
endometriosis, epilepsy, fibromyalgia, food allergies, heart
disease, hemophilia, hidradenitis suppurativa, HIV, hyperhidrosis,
irritable bowel syndrome, leukemia, lung cancer, lupus, lymphoma,
migraines, multiple sclerosis, myeloma, myeloproliferative
neoplasms, narcolepsy, obesity, osteoporosis, ovarian cancer,
Parkinson's, PCOS, prurigo nodularis, psoriasis, pulmonary
hypertension, rheumatoid arthritis, seborrheic dermatitis, spinal
muscular atrophy, spondylitis, and vitiligo. MyHealthTeam social
networks and knowledge centers are available in 13 countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/myhealthteam-and-arcutis-biotherapeutics-launch-new-social-network-for-people-living-with-seborrheic-dermatitis-301691934.html
SOURCE MyHealthTeam